Piramal Pharma Limited

Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. Piramal Pharma Limited includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization, Piramal Critical Care (PCC), a Complex Hospital Generics business; and the India Consumer Healthcare business, selling over-the-counter products.

Piramal Pharma Limited, offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization; Piramal Critical Care (PCC), a Complex Hospital Generics business; and the India Consumer Healthcare business, selling over-the- counter products. In addition, one of PPL’s associate companies, AbbVie Therapeutics India Private Limited is a JV with AbbVie Inc. and has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.

Piramal Pharma Limited is a part of the Piramal Group, a global business conglomerate with diverse interests in pharma, financial services, and real estate. The Group has offices in over 30 countries and a global brand presence in more than 100 markets, and operates with over 10,000 people worldwide from 21 diverse nationalities.

Pharma Solutions

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. PPS serves customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables PPS to offer a comprehensive range of services, including drug discovery solutions, process and pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms.

Critical Care

Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is one of the leaders in inhaled anesthetics and a global player in hospital generics. PCC is motivated by its vision of commitment to delivering critical care solutions for patients and healthcare providers across the globe, while achieving sustainable and profitable growth for all the stakeholders.

Piramal Consumer Healthcare

Piramal Consumer Healthcare (PCH) is one of the fastest-growing businesses of Piramal Pharma Limited. It is among the leading players in the Indian self-care space, with established brands like Littles, Lacto Calamine, i-pill, Tetmosol. Polycrol and Tri-Activ, among others, in the Indian Consumer Healthcare market.

The PCH portfolio consists of branded consumer healthcare and wellness products, primarily in areas of routine health disruption and proactive care, expanding across key over the counter (OTC) categories such as Analgesics, Gastro-Intestinal, Hygiene, Skincare, Vitamins and Supplements, Women Care, Baby Care and Kids’ wellness.

AbbVie Therapeutics India Private Limited

AbbVie Therapeutics India Private Limited (formerly Allergan India Pvt Ltd)., a joint venture between Allergan (now part of AbbVie) and Piramal Pharma Limited, commenced commercial operations in 1996.

AbbVie Therapeutics India Private Limited, a specialty pharmaceutical company, has emerged as the market leader in the fast- growing ophthalmic category with the successful launches of a series of high technology medication and devices for diseases such as glaucoma, dry eye, infections, and inflammations.